ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-04-16 5:13:30 PM | Chg. -0.450 | Volume | Bid5:21:45 PM | Ask5:21:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
128.250EUR | -0.35% | 305 Turnover: 39,276.450 |
128.300Bid Size: 117 | 128.400Ask Size: 117 | 197.83 bill.EUR | - | - |
GlobeNewswire
1:00 PM
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration ...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...